Ventive Hospital Reports Explosive Q1 FY26 Revenue Growth but EPS Falls Sharply.

Ventive Hospital delivered a remarkable top-line performance in the June 2025 quarter, though earnings per share saw a steep decline due to equity dilution and higher share base. Sales soared 342% YoY to ₹507 crore from ₹115 crore in June 2024, driven by strong patient inflow, expansion of specialty services, and higher occupancy rates across facilities. EBIDT surged 206% to ₹208 crore from ₹67.9 crore, reflecting improved operational leverage and cost efficiencies. Net profit inched up 2% YoY to ₹37.9 crore from ₹26.4 crore, as higher depreciation, interest costs, and tax provisions offset much of the operating gains. EPS, however, fell 95% to ₹1.15 from ₹25.30 last year, largely due to a significant increase in the number of outstanding shares following capital raising. At a market price of ₹731 and a market cap of ₹17,073 crore, the stock trades at a PE of 129.6, indicating rich valuations backed by aggressive growth plans and market expansion. Key takeaway: While Ventive Hospital delivered extraordinary revenue and EBIDT growth, the muted net profit and sharp EPS drop highlight the impact of capital structure changes on per-share earnings.